coupled assay
Recently Published Documents


TOTAL DOCUMENTS

101
(FIVE YEARS 6)

H-INDEX

19
(FIVE YEARS 2)

Cell Reports ◽  
2021 ◽  
Vol 36 (1) ◽  
pp. 109311
Author(s):  
Kouichi Yanagi ◽  
Toru Komatsu ◽  
Shusuke Ogihara ◽  
Takayoshi Okabe ◽  
Hirotatsu Kojima ◽  
...  

Life ◽  
2021 ◽  
Vol 11 (6) ◽  
pp. 485
Author(s):  
Francesco Marchesani ◽  
Erika Zangelmi ◽  
Stefano Bruno ◽  
Stefano Bettati ◽  
Alessio Peracchi ◽  
...  

Phosphoserine phosphatase (PSP) catalyzes the final step of de novo L-serine biosynthesis—the hydrolysis of phosphoserine to serine and inorganic phosphate—in humans, bacteria, and plants. In published works, the reaction is typically monitored through the discontinuous malachite green phosphate assay or, more rarely, through a continuous assay that couples phosphate release to the phosphorolysis of a chromogenic nucleoside by the enzyme purine nucleoside phosphorylase (PNP). These assays suffer from numerous drawbacks, and both rely on the detection of phosphate. We describe a new continuous assay that monitors the release of serine by exploiting bacterial serine acetyltransferase (SAT) as a reporter enzyme. SAT acetylates serine, consuming acetyl-CoA and releasing CoA-SH. CoA-SH spontaneously reacts with Ellman’s reagent to produce a chromophore that absorbs light at 412 nm. The catalytic parameters estimated through the SAT-coupled assay are fully consistent with those obtained with the published methods, but the new assay exhibits several advantages. Particularly, it depletes L-serine, thus allowing more prolonged linearity in the kinetics. Moreover, as the SAT-coupled assay does not rely on phosphate detection, it can be used to investigate the inhibitory effect of phosphate on PSP.


BIO-PROTOCOL ◽  
2021 ◽  
Vol 11 (24) ◽  
Author(s):  
Nicholas Moody ◽  
Chatawal Phansopal ◽  
James Reid

2020 ◽  
Vol 92 (7) ◽  
pp. 4971-4979 ◽  
Author(s):  
Kari Kopra ◽  
Emmiliisa Vuorinen ◽  
Maria Abreu-Blanco ◽  
Qi Wang ◽  
Ville Eskonen ◽  
...  

2019 ◽  
Vol 162 ◽  
pp. 9-15 ◽  
Author(s):  
Dan-Dan Shen ◽  
Feng-Zhi Suo ◽  
Qi-Meng Song ◽  
Jiao Chang ◽  
Ting Zhang ◽  
...  

2018 ◽  
Vol 139 ◽  
pp. 95-100 ◽  
Author(s):  
Jyun-Liang Lin ◽  
Holly Ekas ◽  
Kelly Markham ◽  
Hal S. Alper

2018 ◽  
Author(s):  
Tomotaka Mido ◽  
Eric M. Schaffer ◽  
Robert W. Dorsey ◽  
Shanmuga Sozhamannan ◽  
E. Randal Hofmann

AbstractPhages are natural predators of bacteria and have been exploited in bacterial detection because of their exquisite specificity to their cognate bacterial hosts. In this study, we present a bacteriophage amplification-coupled assay as a surrogate for detecting a bacterium present in a sample. The assay entails detection of progeny phage resulting from infection and subsequent growth inside the bacterium present in suspected samples. This approach reduces testing time and enhances sensitivity to identify pathogens compared to traditional overnight plaque assay. Further, the assay has the ability to discriminate between live and dead cells since phages require live host cells to infect and replicate. To demonstrate its utility, phage MS2 amplification-coupled, bead-based sandwich type immunoassay on the Luminex®MAGPIX instrument forEscherichia colidetection was performed. The assay not only showed live cell discrimination ability but also a limit ofE. colidetection of 1×102cells/mL of live cells after a 3-hour incubation. In addition, the sensitivity of the assay was not impaired in the presence of dead cells. These results demonstrate that bacteriophage amplification-coupled assay can be a rapid live cell detection assay compared to traditional culture methods and a promising tool for quick validation of bacterial inactivation. Combined with the unique multiplex bead chemistry afforded by Luminex®MAGPIX platform, the phage assay can be expanded to be an ultra-deep multiplex assay for the simultaneous detection of multiple pathogens using specific phages directed against the target pathogens.


2018 ◽  
Vol 59 (6) ◽  
pp. 1005-1014 ◽  
Author(s):  
Saravanan Devendran ◽  
Sean M. Mythen ◽  
Jason M. Ridlon

Clostridium scindens is a gut microbe capable of removing the side-chain of cortisol, forming 11β-hydro­xyandrostenedione. A cortisol-inducible operon (desABCD) was previously identified in C. scindens ATCC 35704 by RNA-Seq. The desC gene was shown to encode a cortisol 20α-hydroxysteroid dehydrogenase (20α-HSDH). The desD encodes a protein annotated as a member of the major facilitator family, predicted to function as a cortisol transporter. The desA and desB genes are annotated as N-terminal and C-terminal transketolases, respectively. We hypothesized that the DesAB forms a complex and has steroid-17,20-desmolase activity. We cloned the desA and desB genes from C. scindens ATCC 35704 in pETDuet for overexpression in Escherichia coli. The purified recombinant DesAB was determined to be a 142 ± 5.4 kDa heterotetramer. We developed an enzyme-linked continuous spectrophotometric assay to quantify steroid-17,20-desmolase. This was achieved by coupling DesAB-dependent formation of 11β-hydroxyandrostenedione with the NADPH-dependent reduction of the steroid 17-keto group by a recombinant 17β-HSDH from the filamentous fungus, Cochliobolus lunatus. The pH optimum for the coupled assay was 7.0 and kinetic constants using cortisol as substrate were Km of 4.96 ± 0.57 µM and kcat of 0.87 ± 0.076 min−1. Substrate-specificity studies revealed that rDesAB recognized substrates regardless of 11β-hydroxylation, but had an absolute requirement for 17,21-dihydroxy 20-ketosteroids.


2017 ◽  
Vol 94 ◽  
pp. 460-470 ◽  
Author(s):  
Stanislav Pepeliaev ◽  
Radka Hrudíková ◽  
Jana Jílková ◽  
Jaroslav Pavlík ◽  
Dzianis Smirnou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document